Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits

Retina

Volumn 26, Issue 3, 2006, Pages 339-344

  Morrison, Victoria L ^a   Koh, Hyoung J ^a   Cheng, Lingyun ^a   Bessho, Kenichiro ^a   Davidson, Marie C ^a   Freeman, William R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Benzyl alcohol; Intravitreal Kenalog; Ocular toxicity; Rabbit

Indexed keywords

BENZYL ALCOHOL; TRIAMCINOLONE ACETONIDE; DRUG VEHICLE; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENUCLEATION; EYE; MICROSCOPY; NONHUMAN; PHOTORECEPTOR; RABBIT; RETINA; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRORETINOGRAPHY; INJECTION; PATHOLOGY; RETINA DISEASE; VEHICLES; VITREOUS BODY;

ANIMALS; BENZYL ALCOHOL; ELECTRORETINOGRAPHY; GLUCOCORTICOIDS; INJECTIONS; RABBITS; RETINA; RETINAL DISEASES; TRIAMCINOLONE ACETONIDE; VEHICLES; VITREOUS BODY;

EID: 33646448054     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200603000-00014     Document Type: Article

References (41)

1. Schindler RH, Chandler D, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982;93:415-417.
2. Jonas JB, Kreissig I, Degenring R. Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2002;240:873-874.
3. Jonas JB, Kreissig I, Hugger P, et al. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-468.
4. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration. Arch Ophthalmol 2003;121:667-673.
5. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003;110:1517-1525.
6. Rechtman E, Allen VD, Danis RP, et al. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 2003;136:739-741.
7. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-783.
8. Jonas JB, Söfker A. Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization. J Cataract Refract Surg 2002;28:2040-2041.
9. Jonas JB, Kreissig I, Söfker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
10. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
11. Benhamou N, Massin P, Haouchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 2003;135:246-249.
12. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003;136:384-386.
13. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitis cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-772.
14. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003;87:361.
15. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419-425.
16. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
17. Scott IU, Flynn HW, Rosenfeld PJ. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol 2003;136:737-739.
18. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468-471.
19. Jonas JB, Sofker A, Degenring R. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2003;13:468-473.
20. Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 2002;240:423-429.
21. Gershanik J, Boecler B, Ensley H, et al. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982;307:1384-1388.
22. Brown WJ, Buist NR, Gipson HT, et al. Fatal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet 1982;1:1250.
23. Benzyl alcohol may be toxic to newborns. FDA Drug Bull 1982;12:10-11.
24. Benda GI, Hiller JL, Reynolds JW. Benzyl alcohol toxicity: impact on neurologic handicaps among surviving very low birth weight infants. Pediatrics 1986;77:507-512.
25. Hiller JL, Benda GI, Rahatzad M, et al. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics 1986;77:500-506.
26. DeLand FH. Intrathecal toxicity studies with benzyl alcohol. Toxicol Appl Pharmacol 1973;25:153-156.
27. Feasby TE, Hahn AF, Gilbert JJ. Neurotoxicity of bacteriostatic water. N Engl J Med 1983;308:966-967.
28. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003;87:972-974.
29. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.
30. Nelson ML, Tennant MT, Sivalingam A, et al. Infectious and presumed non-infectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686-691.
31. Kumar A, Prakash G, Nainiwal S. Management of iatrogenic intravitreal triamcinolone acetonide. Indian J Ophthalmol 2003;51:180-181.
32. Cheng L, Hostetler KY, Chaidhawangul S, et al. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phosphoganciclovir. Invest Ophthalmol Vis Sci 2002;43:515-521.
33. McCuen BW II, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981;91:785-788.
34. Yeung CK, Chan KP, Chiang SW, et al. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 2003;44:5293-5300.
35. Walter P, Luck C, Sickel W. Antibiotics and light responses in superfused bovine retina. Cell Mol Neurobiol 1999;19:87-92.
36. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986;101:190-195.
37. McCloskey SE, Gershanik JJ, Lertora JJ, et al. Toxicity of benzyl alcohol in adult and neonatal mice. J Pharm Sci 1986;75:702-705.
38. LeBel M, Ferron L, Masson M, et al. Benzyl alcohol metabolism and elimination in neonates. Dev Pharmacol Ther 1988;11:347-356.
39. Kimura ET, Darby TD, Krause RA, Brondyk HD. Parenteral toxicity studies with benzyl alcohol. Toxicol Appl Pharmacol 1971;18:60-68.
40. Rodriguez-Coleman H, Yuan P, Kim H, et al. Intravitreal injection of triamcinolone for diffuse macular edema. Arch Ophthalmol 2004;122:1085-1086.
41. Jonas JB, Degenring RF, Kreissig I. Intravitreal injection of triamcinolone for diffuse macular edema. Authors reply. Arch Ophthalmol 2004;122:1086-1088.